Ertapenem Impurity 19 | CAS 770703-11-2 - Request Quote
Ertapenem Impurity 19
| SZ CAT No: | SZ-E049035 |
| CAS No | 770703-11-2 |
| Mol.F. | C12H14N2O4 |
| Mol.Wt. | 250.3 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 444057-65-2 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ertapenem Impurity 19 is chemically 3-((2S,4R)-4-hydroxypyrrolidine-2-carboxamido)benzoic acid. Ertapenem Impurity 19 is supplied with detailed characterization data compliant with regulatory guideline. Ertapenem Impurity 19 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ertapenem.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 770703-11-2
Purchase 770703-11-2
Order 770703-11-2
Enquire 770703-11-2
price of 770703-11-2
770703-11-2 Supplier
770703-11-2 Manufacturer
770703-11-2 Exporter
buy high quality Ertapenem Impurity 19
Purchase Ertapenem Impurity 19
Ertapenem Impurity 19 suppliers
Ertapenem Impurity 19 manufacturers
Ertapenem Impurity 19 price
Order Ertapenem Impurity 19
Enquire Ertapenem Impurity 19
Ertapenem Impurity 19 cost
Ertapenem Impurity 19 Supplier
Ertapenem Impurity 19 Distributor
Ertapenem Impurity 19 for Method Validation
Ertapenem Reference Standard
Ertapenem Impurity 19 for ANDA Filing
Ertapenem Impurity 19 for Forced Degradation Studies
Ertapenem Impurity 19 Identification Standards
Ertapenem Impurity 19 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


